The pharmaceutical companies are considered as one of the most influential interest groups within drug policy, or in general within healthcare system. Therefore, this diploma thesis is focused on the influence of the pharmaceutical manufacturers on legislative framework that forms the drug policy, on the impact on the concrete implementation of drug policy and finally on the influence on prescription, sales and public opinion. Based on an analysis of the pharmaceutical market and the drug policy of the Czech Republic, the diploma thesis defines the most common interests of the pharmaceutical companies which they are trying to push through lobbying. Furthermore, the thesis identifies the access points through which these interests can push through and tries to illustrate these facts on concrete examples.
| Identifer | oai:union.ndltd.org:nusl.cz/oai:invenio.nusl.cz:193707 |
| Date | January 2013 |
| Creators | Škrobáková, Irena |
| Contributors | Vymětal, Petr, Matějková, Adéla |
| Publisher | Vysoká škola ekonomická v Praze |
| Source Sets | Czech ETDs |
| Language | Czech |
| Detected Language | English |
| Type | info:eu-repo/semantics/masterThesis |
| Rights | info:eu-repo/semantics/restrictedAccess |
Page generated in 0.0014 seconds